| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

( Departments of Biochemistry and Surgery, College of Physicians and Surgeons, Columbia University, New York, N.Y.)
hour prior to the administration of deoxypyridoxine was observed to protect glutamic-aspartic transaminase from deoxypyridoxine inhibition regardless of whether the antagonist was given alone or in combination with the testosterone. * This work was supported by a grant-in-aid from the Damon Runyon Memorial Fund, the Mary Madison McGuire Memorial Fund and an anonymous cancer gift. A preliminary report appeared in Fed. Proc., 12:412, 1953.
Fellow of the Dazian Foundation for Medical Research, Inc.
Received 11/ 3/54.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |